{"component": "contracts", "props": {"contracts": [{"intro": "", "id": "1XK8gcBPMv8", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000095015099000401/2.txt", "category_name": "Security Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "March 31st, 1999", "published": true, "pretty": null, "uri": "/contracts/1XK8gcBPMv8", "title": "WITNESSETH:", "group_id": "1XK8gcBPMv8", "group_samples": [{"label": "Security Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/1XK8gcBPMv8", "published": true}], "group_size": 1, "tags": [{"name": "Security Agreement", "type": "category", "uri": "/contracts/tagged/security-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Illinois", "type": "jurisdiction", "uri": "/contracts/tagged/illinois-us"}]}, {"intro": "", "id": "3Tft5Fnp8Vc", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000089161898000272/2.txt", "category_name": "Core Technology Development and License Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "January 29th, 1998", "published": true, "pretty": null, "uri": "/contracts/3Tft5Fnp8Vc", "title": "CORE TECHNOLOGY DEVELOPMENT AND LICENSE AGREEMENT by and between MICROCIDE PHARMACEUTICALS, INC. and EPIGENIX, INC.", "group_id": "3Tft5Fnp8Vc", "group_samples": [{"label": "Core Technology Development and License Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/3Tft5Fnp8Vc", "published": true}], "group_size": 1, "tags": [{"name": "Core Technology Development and License Agreement", "type": "category", "uri": "/contracts/tagged/core-technology-development-and-license-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "", "id": "694NRr5pwwX", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000089161897003453/1.txt", "category_name": "Synthetic Compound Purchase Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "August 14th, 1997", "published": true, "pretty": null, "uri": "/contracts/694NRr5pwwX", "title": "1 EXHIBIT 10.18 SYNTHETIC COMPOUND PURCHASE AGREEMENT This Synthetic Compound Purchase Agreement (\"Agreement\"), is effective as of June 25, 1997 (\"Effective Date\"), by and between Microcide Pharmaceuticals, Inc. (\"Microcide\"), a Delaware corporation,...", "group_id": "694NRr5pwwX", "group_samples": [{"label": "Synthetic Compound Purchase Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/694NRr5pwwX", "published": true}], "group_size": 1, "tags": [{"name": "Synthetic Compound Purchase Agreement", "type": "category", "uri": "/contracts/tagged/synthetic-compound-purchase-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "", "id": "7DNxg5Vewoi", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000089161801500767/f72561ex10-1.txt", "category_name": "Severance Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "May 15th, 2001", "published": true, "pretty": null, "uri": "/contracts/7DNxg5Vewoi", "title": "EXHIBIT 10.1 SEVERANCE AGREEMENT THIS AGREEMENT is entered into as of March 26, 2001, by and between ___________ (the \"Employee\") and MICROCIDE PHARMACEUTICALS, INC., a Delaware corporation (the \"Company\"). 1. Term of Agreement. This Agreement shall...", "group_id": "7DNxg5Vewoi", "group_samples": [{"label": "Severance Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/7DNxg5Vewoi", "published": true}], "group_size": 1, "tags": [{"name": "Severance Agreement", "type": "category", "uri": "/contracts/tagged/severance-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "This amendment reflects an increase to the Research Agreement by $[ * ] from $[ * ] to $[ * ] and to extend the period of performance to December 31, 2002. The Research Agreement is revised as follows:", "id": "8pvuoi6LuAP", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000119312503077873/dex105.htm", "category_name": "Research Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 12th, 2003", "published": true, "pretty": null, "uri": "/contracts/8pvuoi6LuAP", "title": "CONFIDENTIAL TREATMENT AMENDMENT NO. 3 to the RESEARCH AGREEMENT dated July 13, 2000 between the UNIVERSITY OF SOUTHERN CALIFORNIA and MARET CORPORATION March 18,2002", "group_id": "8pvuoi6LuAP", "group_samples": [{"label": "Research Agreement (Essential Therapeutics Inc)", "uri": "/contracts/8pvuoi6LuAP", "published": true}], "group_size": 1, "tags": [{"name": "Research Agreement", "type": "category", "uri": "/contracts/tagged/research-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This amendment reflects an increase to the Research Agreement by $[*] (see Exhibit B) from $[*] to $[*] and defines Research Work to be performed in the Statement of Work attached and incorporated in this amendment as Exhibit A, for the period April 1, 2002 through March 31, 2003. The Research Agreement is revised as follows:", "id": "9LCgZ6QluTP", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000102140802010871/dex101.htm", "category_name": "Research Agreement", "company_name": "Essential Therapeutics Inc", "created": "August 14th, 2002", "published": true, "pretty": null, "uri": "/contracts/9LCgZ6QluTP", "title": "CONFIDENTIAL TREATMENT AMENDMENT NO. 4 to the RESEARCH AGREEMENT dated July 13, 2000 between the UNIVERSITY OF SOUTHERN CALIFORNIA and MARET CORPORATION June 24, 2002", "group_id": "9LCgZ6QluTP", "group_samples": [{"label": "Research Agreement (Essential Therapeutics Inc)", "uri": "/contracts/9LCgZ6QluTP", "published": true}], "group_size": 1, "tags": [{"name": "Research Agreement", "type": "category", "uri": "/contracts/tagged/research-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "9gI2rEKMOnh", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000119312503077873/dex107.htm", "category_name": "License Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 12th, 2003", "published": true, "pretty": null, "uri": "/contracts/9gI2rEKMOnh", "title": "CONFIDENTIAL TREATMENT AMENDMENT NO. 1 TO LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF SOUTHERN CALIFORNIA AND MARET CORPORATION", "group_id": "9gI2rEKMOnh", "group_samples": [{"label": "License Agreement (Essential Therapeutics Inc)", "uri": "/contracts/9gI2rEKMOnh", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "9y29eOapw4X", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000095015099000401/3.txt", "category_name": "Research and License Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "March 31st, 1999", "published": true, "pretty": null, "uri": "/contracts/9y29eOapw4X", "title": "1 Exhibit 10.25 AMENDMENT OF RESEARCH AND LICENSE AGREEMENT This Amendment is made effective as of the 23rd day of October, 1998 (the \"Amendment Date\") by and between Microcide Pharmaceuticals, Inc., a corporation organized under Delaware law having...", "group_id": "9y29eOapw4X", "group_samples": [{"label": "Research and License Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/9y29eOapw4X", "published": true}], "group_size": 1, "tags": [{"name": "Research and License Agreement", "type": "category", "uri": "/contracts/tagged/research-and-license-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "This amendment reflects an increase to the Research Agreement by $[ * ] from $[ * ] to $[ * ] and to extend the period of performance to December 31, 2001. The Research Agreement is revised as follows:", "id": "YSVM9ZYT6E", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000119312503077873/dex104.htm", "category_name": "Research Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 12th, 2003", "published": true, "pretty": null, "uri": "/contracts/YSVM9ZYT6E", "title": "CONFIDENTIAL TREATMENT AMENDMENT NO. 2 to the RESEARCH AGREEMENT dated July 13, 2000 between the UNIVERSITY OF SOUTHERN CALIFORNIA and MARET CORPORATION January 16, 2001", "group_id": "YSVM9ZYT6E", "group_samples": [{"label": "Research Agreement (Essential Therapeutics Inc)", "uri": "/contracts/YSVM9ZYT6E", "published": true}], "group_size": 1, "tags": [{"name": "Research Agreement", "type": "category", "uri": "/contracts/tagged/research-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "a19ICUcHFK7", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000095015099000401/4.txt", "category_name": "Collaborative Research Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "March 31st, 1999", "published": true, "pretty": null, "uri": "/contracts/a19ICUcHFK7", "title": "1 Exhibit 10.26 COLLABORATIVE RESEARCH AGREEMENT THIS COLLABORATIVE RESEARCH AGREEMENT is entered into as of the Effective Date by and between PFIZER INC, a Delaware corporation, having an office at 235 East 42nd Street, New York, NY 10017 and its...", "group_id": "a19ICUcHFK7", "group_samples": [{"label": "Collaborative Research Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/a19ICUcHFK7", "published": true}], "group_size": 1, "tags": [{"name": "Collaborative Research Agreement", "type": "category", "uri": "/contracts/tagged/collaborative-research-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "", "id": "cCDTaZEDsXW", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000089161897004682/1.txt", "category_name": "Sublease", "company_name": "Microcide Pharmaceuticals Inc", "created": "November 14th, 1997", "published": true, "pretty": null, "uri": "/contracts/cCDTaZEDsXW", "title": "SUBLEASE", "group_id": "cCDTaZEDsXW", "group_samples": [{"label": "Sublease (Microcide Pharmaceuticals Inc)", "uri": "/contracts/cCDTaZEDsXW", "published": true}], "group_size": 1, "tags": [{"name": "Sublease", "type": "category", "uri": "/contracts/tagged/sublease"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "This letter agreement will set forth certain understandings between Essential Therapeutics, Inc., a Delaware corporation (the \u201cBorrower\u201d) and Fleet National Bank (the \u201cBank\u201d) with respect to Term Loans (hereinafter defined) to be made by the Bank to the Borrower. In consideration of the mutual promises contained herein and in the other documents referred to below, and for other good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, the Borrower and the Bank agree as follows:", "id": "cHFXGFLqNv4", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000101287002004408/dex101.htm", "category_name": "Term Loan Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 14th, 2002", "published": true, "pretty": null, "uri": "/contracts/cHFXGFLqNv4", "title": "ESSENTIAL THERAPEUTICS, INC. Waltham, MA 02451", "group_id": "cHFXGFLqNv4", "group_samples": [{"label": "Term Loan Agreement (Essential Therapeutics Inc)", "uri": "/contracts/cHFXGFLqNv4", "published": true}], "group_size": 1, "tags": [{"name": "Term Loan Agreement", "type": "category", "uri": "/contracts/tagged/term-loan-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Massachusetts", "type": "jurisdiction", "uri": "/contracts/tagged/massachusetts-us"}]}, {"intro": "", "id": "d9ZaZnUt0F9", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000095015099000401/5.txt", "category_name": "License Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "March 31st, 1999", "published": true, "pretty": null, "uri": "/contracts/d9ZaZnUt0F9", "title": "1 Exhibit 10.27 LICENSE AND ROYALTY AGREEMENT This LICENSE AND ROYALTY AGREEMENT is entered into as of January 13, 1999 (the \"Effective Date\") by and between PFIZER INC, a Delaware corporation, having an office at 235-East 42nd Street, New York, NY...", "group_id": "d9ZaZnUt0F9", "group_samples": [{"label": "License Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/d9ZaZnUt0F9", "published": true}], "group_size": 1, "tags": [{"name": "License Agreement", "type": "category", "uri": "/contracts/tagged/license-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This amendment reflects an increase to the Research Agreement by $[ * ] from $[ * ] to $[ * ] and to extend the period of performance to March 31, 2001. The Research Agreement is revised as follows:", "id": "e0zrMh2EfKe", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000119312503077873/dex103.htm", "category_name": "Research Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 12th, 2003", "published": true, "pretty": null, "uri": "/contracts/e0zrMh2EfKe", "title": "CONFIDENTIAL TREATMENT AMENDMENT NO. 1 to the RESEARCH AGREEMENT dated July 13, 2000 between the UNIVERSITY OF SOUTHERN CALIFORNIA and MARET CORPORATION January 16, 2001", "group_id": "e0zrMh2EfKe", "group_samples": [{"label": "Research Agreement (Essential Therapeutics Inc)", "uri": "/contracts/e0zrMh2EfKe", "published": true}], "group_size": 1, "tags": [{"name": "Research Agreement", "type": "category", "uri": "/contracts/tagged/research-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "fZO0qsEYZzM", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000095000500000756/0002.txt", "category_name": "Joint Research Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "June 19th, 2000", "published": true, "pretty": null, "uri": "/contracts/fZO0qsEYZzM", "title": "AMENDMENT TO JOINT RESEARCH AGREEMENT DAIICHI PHARMACEUTICAL CO., LTD., a corporation organized and existing under the laws of Japan, and having its registered office at 14-10, Nihonbashi 3-chome, Chuo-Ku, Tokyo, Japan (hereinafter called \"DAIICHI\")...", "group_id": "fZO0qsEYZzM", "group_samples": [{"label": "Joint Research Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/fZO0qsEYZzM", "published": true}], "group_size": 1, "tags": [{"name": "Joint Research Agreement", "type": "category", "uri": "/contracts/tagged/joint-research-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "gnyQ6oqKK0n", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000119312503077873/dex106.htm", "category_name": "Licensing Agreement", "company_name": "Essential Therapeutics Inc", "created": "November 12th, 2003", "published": true, "pretty": null, "uri": "/contracts/gnyQ6oqKK0n", "title": "CONFIDENTIAL TREATMENT USC FILE 2146B (Gere S. diZerega) USC FILE 2429 (Gere S. diZerega and Kathleen E. Rodgers) USC FILE 2430 (Gere S. diZerega and Kathleen E. Rodgers) TISSUE REPAIR SUBSTANCE", "group_id": "gnyQ6oqKK0n", "group_samples": [{"label": "Licensing Agreement (Essential Therapeutics Inc)", "uri": "/contracts/gnyQ6oqKK0n", "published": true}], "group_size": 1, "tags": [{"name": "Licensing Agreement", "type": "category", "uri": "/contracts/tagged/licensing-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "California", "type": "jurisdiction", "uri": "/contracts/tagged/california-us"}]}, {"intro": "", "id": "jEvdQYLI6e0", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000089161801000242/f70591a1ex10-32.txt", "category_name": "Research and License Agreement", "company_name": "Microcide Pharmaceuticals Inc", "created": "March 21st, 2001", "published": true, "pretty": null, "uri": "/contracts/jEvdQYLI6e0", "title": "1 EXHIBIT 10.32 AMENDMENT NUMBER 2 TO RESEARCH AND LICENSE AGREEMENT BY AND BETWEEN MICROCIDE PHARMACEUTICALS, INC., ORTHO PHARMACEUTICAL CORPORATION AND R.W. JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE This Amendment Number 2 (\"AMENDMENT NO. 2\"), dated...", "group_id": "jEvdQYLI6e0", "group_samples": [{"label": "Research and License Agreement (Microcide Pharmaceuticals Inc)", "uri": "/contracts/jEvdQYLI6e0", "published": true}], "group_size": 1, "tags": [{"name": "Research and License Agreement", "type": "category", "uri": "/contracts/tagged/research-and-license-agreement"}, {"name": "Microcide Pharmaceuticals Inc", "type": "company", "uri": "/company/1010915/microcide-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "", "id": "k25P9L8usTa", "source_url": "https://www.sec.gov/Archives/edgar/data/1010915/000101287002001433/dex101.txt", "category_name": "Convertible Note and Bonus Payment Agreement", "company_name": "Essential Therapeutics Inc", "created": "March 25th, 2002", "published": true, "pretty": null, "uri": "/contracts/k25P9L8usTa", "title": "CONVERTIBLE NOTE AND BONUS PAYMENT AGREEMENT", "group_id": "k25P9L8usTa", "group_samples": [{"label": "Convertible Note and Bonus Payment Agreement (Essential Therapeutics Inc)", "uri": "/contracts/k25P9L8usTa", "published": true}], "group_size": 1, "tags": [{"name": "Convertible Note and Bonus Payment Agreement", "type": "category", "uri": "/contracts/tagged/convertible-note-and-bonus-payment-agreement"}, {"name": "Essential Therapeutics Inc", "type": "company", "uri": "/company/1010915/essential-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}], "next_curs": "", "cursor": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLMUVrMnAyRVkzWnoYACAB"}}